The global flavomycin market size was approximately USD million in 2023 and is expected to reach USD million by 2030, registering a compound annual growth rate (CAGR) of % during 2024-2030. In terms of sales volume, global flavofulin sales volume was , and is expected to reach by 2030, growing at a CAGR of %.
In this study, flavomycin, fl**omycin, cas 11015-37-5
Flavofulin product type.
Feed grade flavomycin.
Industrial-grade flavomycin.
Flavomycin application.
Poultry feed. Cattle feed.
The main regions included in this article are Countries:
Americas region. United States.
Canada. Mexico.
Brazil. Asia pacific.
China. Japan.
Korea. Southeast Asia.
India. Australia.
Europe. Germany.
France. United Kingdom.
Italy. Russia.
Middle East & Africa.
Egypt. South Africa.
Israel. Turkey.
Gulf countries.
This article mainly includes the following companies:
merck animal health
biovet
elanco animal health
ewha pharmtek
shandong qilu king-phar pharmaceutical
zhejiang qianjiang biochemical
shenghua group
zhejiang shenghua biok biology
guangzhou haicheng pharmaceutical
zhejiang university sunny nutrition technology
This product is light brown to brown powder; It smells bad. Flavofulin is a phosphorylated polysaccharide antibiotic, and its antibacterial mechanism of action is to inhibit the reproduction of bacteria by interfering with the biosynthesis of peptidoglycan, a structural substance in the cell wall. The principle of growth promotion of flavomycin may lie in its ability to improve the digestion of energy and protein in feed; It can thin the intestinal wall to improve the absorption of nutrients;